AI advancements target clinical decision support and medical imaging reliability

Developments in medical artificial intelligence are moving beyond simple image analysis toward clinical decision support and improved structural reliability.

Qure.ai, a Mumbai-founded company, has received Class IIb CE certification under the European Union’s Medical Device Regulation for its Aira clinical decision support system. Designed for frontline healthcare in emerging economies, Aira acts as an AI layer that integrates patient histories, clinical guidelines, and documentation to assist in clinical workflows. The Class IIb designation indicates the software supports decisions that could result in serious health deterioration or require surgical intervention.

In parallel, researchers at Umeå University in Sweden have developed structure-aware AI methods to improve the reliability of medical image analysis. By incorporating anatomical information and mathematical morphology into machine learning models, the system ensures that predictions align with real anatomical boundaries. This approach, which includes uncertainty-awareness to signal confidence levels to clinicians, has been explored for classifying Alzheimer’s disease by identifying connected regions of structural brain changes.